Literature DB >> 22522964

Development and validation of a sensitive LC/MS/MS method for the determination of γ-tocotrienol in rat plasma: application to pharmacokinetic studies.

Su Liang1, Xiaomei Bian, Jing Ma, Motolani Arogunjo, Amit A Deorukhkar, Sunil Krishnan, Huan Xie.   

Abstract

γ-Tocotrienol has attracted much attention owing to its multiple health benefits. This study developed and validated a simple, specific, sensitive and reliable LC/MS/MS method to analyze γ-tocotrienol in rat plasma. Plasma samples (50 μL) were extracted with internal standard solution (25 ng/mL of itraconazole) in acetonitrile (200 μL) with an average recovery of 44.7% and an average matrix effect of -2.9%. The separation of γ-tocotrienol and internal standard from the plasma components was achieved with a Waters XTerra® MS C(18) column with acetonitrile-water as mobile phase. Analysis was performed under positive ionization electrospray mass spectrometer via the multiple reaction monitoring. The standard curve was linear over a concentration range of 10-1000 ng/mL with correlation coefficient values >0.997. The method was validated with intra- and inter-day accuracy (relative error) ranging from 1.79 to 9.17% and from 2.16 to 9.66%, respectively, and precision (coefficient of variation) ranged from 1.94 to 9.25% and from 2.37 to 10.08%, respectively. Short-term stability, freeze-thaw stability and the processed sample stability tests were performed. This method was further applied to analyze γ-tocotrienol plasma concentrations in rats at various time points after administration of a 2 mg/kg single intravenous dose, and a pharmacokinetic profile was successfully obtained.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22522964      PMCID: PMC3696499          DOI: 10.1002/bmc.2748

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  20 in total

1.  {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.

Authors:  Ajaikumar B Kunnumakkara; Bokyung Sung; Jayaraj Ravindran; Parmeswaran Diagaradjane; Amit Deorukhkar; Sanjit Dey; Cemile Koca; Vivek R Yadav; Zhimin Tong; Juri G Gelovani; Sushovan Guha; Sunil Krishnan; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2010-09-23       Impact factor: 12.701

2.  Mechanisms underlying the radioprotective properties of γ-tocotrienol: comparative gene expression profiling in tocol-treated endothelial cells.

Authors:  Maaike Berbée; Qiang Fu; Marjan Boerma; K Sree Kumar; David S Loose; Martin Hauer-Jensen
Journal:  Genes Nutr       Date:  2011-04-24       Impact factor: 5.523

3.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

4.  Tocotrienols confer resistance to ischemia in hypercholesterolemic hearts: insight with genomics.

Authors:  Somak Das; Subhendu Mukherjee; Istvan Lekli; Narasimman Gurusamy; Jayeeta Bardhan; Utpal Raychoudhury; Runu Chakravarty; Sandip Banerji; Anne A Knowlton; Dipak K Das
Journal:  Mol Cell Biochem       Date:  2011-09-15       Impact factor: 3.396

5.  Quantitation of itraconazole in rat heparinized plasma by liquid chromatography-mass spectrometry.

Authors:  M Yao; L Chen; N R Srinivas
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-03-05

6.  γ-Tocotrienol protects against mitochondrial dysfunction and renal cell death.

Authors:  Grazyna Nowak; Diana Bakajsova; Corey Hayes; Martin Hauer-Jensen; Cesar M Compadre
Journal:  J Pharmacol Exp Ther       Date:  2011-10-31       Impact factor: 4.030

7.  Preparation and in vivo evaluation of a water-soluble prodrug for 2R-gamma-tocotrienol and as a two-step prodrug for 2,7,8-trimethyl-2S-(beta-carboxyethyl)-6-hydroxychroman (S-gamma-CEHC) in rat.

Authors:  Nami Akaho; Jiro Takata; Takeshi Fukushima; Kazuhisa Matsunaga; Akihiro Hattori; Ryoji Hidaka; Kosuke Fukui; Miyako Yoshida; Toshihiro Fujioka; Yoshiharu Karube; Kazuhiro Imai
Journal:  Drug Metab Dispos       Date:  2007-05-30       Impact factor: 3.922

8.  Normal phase high-performance liquid chromatography method for the determination of tocopherols and tocotrienols in cereals.

Authors:  Gianfranco Panfili; Alessandra Fratianni; Mario Irano
Journal:  J Agric Food Chem       Date:  2003-07-02       Impact factor: 5.279

9.  Cardioprotection with palm oil tocotrienols: comparision of different isomers.

Authors:  Samarjit Das; Istvan Lekli; Manika Das; Gergo Szabo; Judit Varadi; Bela Juhasz; Istvan Bak; Kalanithi Nesaretam; Arpad Tosaki; Saul R Powell; Dipak K Das
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-12-14       Impact factor: 4.733

10.  Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries.

Authors:  Asaf A Qureshi; Charles W Karpen; Nilofer Qureshi; Christopher J Papasian; David C Morrison; John D Folts
Journal:  Lipids Health Dis       Date:  2011-04-14       Impact factor: 3.876

View more
  4 in total

1.  Quantification of a New Anti-Cancer Molecule MJC13 Using a Rapid, Sensitive, and Reliable Liquid Chromatography-Tandem Mass Spectrometry Method.

Authors:  Su Liang; Xiaomei Bian; Jeffrey Sivils; Leonard M Neckers; Marc B Cox; Huan Xie
Journal:  Am J Mod Chromatogr       Date:  2014

2.  Development of PLGA-based itraconazole injectable nanospheres for sustained release.

Authors:  Xiaomei Bian; Su Liang; Jyothy John; Cheng-Hui Hsiao; Xin Wei; Dong Liang; Huan Xie
Journal:  Int J Nanomedicine       Date:  2013-11-21

Review 3.  Vitamin E Analogs as Radiation Response Modifiers.

Authors:  Pankaj K Singh; Sunil Krishnan
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-20       Impact factor: 2.629

4.  γ-Tocotrienol suppresses growth and sensitises human colorectal tumours to capecitabine in a nude mouse xenograft model by down-regulating multiple molecules.

Authors:  Sahdeo Prasad; Subash C Gupta; Amit K Tyagi; Bharat B Aggarwal
Journal:  Br J Cancer       Date:  2016-08-30       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.